X4 Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates

• click to rate

  Posted by Two Blokes May 1 - Filed in Stock - 3 views
  
  4WARD Phase 3 chronic neutropenia trial in full swing; full enrollment on track for 3Q or 4Q 2025 and top-line data in 2H 2026